To view this email as a web page, click here.
 
PHARMACISTS' REPORT
 
FDA Approves Turalio (Pexidartinib) for TGCT
image description here Kinase inhibitor oral capsules.

Read more
 
Birth Weight, Due Date, and COPD
image description here Natal conditions may influence susceptibility.

Read more
 
FDA Issues Warning to CBD Product Suppliers
image description here Companies have been promoting unsubstantiated health and treatment claims.

Read more
 
ADVERTISEMENT
Guide safe and effective drug therapy
Your pharmacists are trusted to guide optimal drug treatment. Where can they go for quick answers backed by deep evidence? Rely on Clinical Pharmacology powered by ClinicalKey for continuous updates by PharmD experts. Try it free
 
Read More
 
CBD Products: Confusion, Hype, and Hope
The Future of Rebates: The Black Swan Scenario
Avoiding Pharmacist Burnout
Specialty Pharmacies on the Rise
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.